CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.12
+0.39 (4.01%)
At close: Oct 11, 2024, 4:00 PM
10.14
+0.02 (0.20%)
After-hours: Oct 11, 2024, 7:41 PM EDT
CorMedix Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CorMedix stock have an average target of 12.6, with a low estimate of 9.00 and a high estimate of 19. The average target predicts an increase of 24.51% from the current stock price of 10.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2024.
Analyst Ratings
The average analyst rating for CorMedix stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +28.46% | Aug 26, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $9 | Buy | Reiterates | $9 | -11.07% | Aug 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | -1.19% | Aug 15, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +18.58% | Jul 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | -1.19% | Jun 19, 2024 |
Financial Forecast
Revenue This Year
30.47M
Revenue Next Year
93.48M
from 30.47M
Increased by 206.77%
EPS This Year
-0.60
from -0.91
EPS Next Year
0.11
from -0.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 40.8M | 116.2M | 210.0M | ||
| Avg | 30.5M | 93.5M | 172.9M | ||
| Low | 23.1M | 68.9M | 136.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 281.3% | 124.6% | ||
| Avg | - | 206.8% | 85.0% | ||
| Low | - | 126.1% | 45.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.39 | 0.62 | 1.90 | ||
| Avg | -0.60 | 0.11 | 1.26 | ||
| Low | -0.73 | -0.37 | 0.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,709.0% | ||
| Avg | - | - | 1,099.0% | ||
| Low | - | - | 515.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.